Revive Therapeutics Ltd RVVTF:OTCQB

*Data is delayed | Exchange | USD
Last | 04/24/24 EDT
0.0215quote price arrow up+0.0014 (+6.9652%)
Volume
153,490
52 week range
0.02 - 0.07
Loading...
  • Open0.0185
  • Day High0.022
  • Day Low0.0185
  • Prev Close0.0201
  • 52 Week High0.07
  • 52 Week High Date04/26/23
  • 52 Week Low0.02
  • 52 Week Low Date03/07/24

Key Stats

  • Market Cap9.12M
  • Shares Out418.56M
  • 10 Day Average Volume205,593.8
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-2.27

KEY STATS

  • Open0.0185
  • Day High0.022
  • Day Low0.0185
  • Prev Close0.0201
  • 52 Week High0.07
  • 52 Week High Date04/26/23
  • 52 Week Low0.02
  • 52 Week Low Date03/07/24
  • Market Cap9.12M
  • Shares Out418.56M
  • 10 Day Average Volume205,593.8
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-2.27

RATIOS/PROFITABILITY

  • EPS (TTM)-0.01
  • P/E (TTM)-2.22
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Revive Therapeutics Ltd

 

Profile

MORE
Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics for rare disorders and infectious diseases. The Company is exploring the use of Bucillamine for the treatment of infectious diseases, with an initial focus on severe influenza and COVID-19. Through its subsidiary, Psilocin Pharma Corp., the Company is advancing the development of Psilocybin-based therapeutics in various diseases and...
Michael Frank
Executive Chairman of the Board, Chief Executive Officer
Carmelo Marrelli
Chief Financial Officer, Corporate Secretary
Address
82 Richmond Street East
Toronto, ON
M5C 1P1
Canada